Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity

Applied Microbiology and Biotechnology

Volumn 97, Issue 10, 2013, Pages 4333-4342

  Berlec, Aleš ^a   Malovrh, Tadej ^b   Zadravec, Petra ^a,b   Steyer, Andrej ^b   Ravnikar, Matjaž ^b   Sabotič, Jerica ^a   Poljšak Prijatelj, Mateja ^b   Štrukelj, Borut ^a,b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Hepatitis A; Immune response; Lactococcus lactis; Oral delivery; Vaccine

Indexed keywords

HEPATITIS A; HUMORAL IMMUNE RESPONSE; IMMUNE RESPONSE; LACTIC ACID BACTERIA; LACTOCOCCUS LACTIS; ORAL DELIVERY; PARENTERAL ADMINISTRATION; RECOMBINANT EXPRESSION;

BACTERIA; DEVELOPING COUNTRIES; ESCHERICHIA COLI; IMMUNE SYSTEM; VACCINES; VIRUSES;

EPITOPES;

EPITOPE; FLAGELLIN; HEPATITIS VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; NISIN; RECOMBINANT HEPATITIS A VIRUS ANTIGEN VP1 P2A; UNCLASSIFIED DRUG;

ANTIBODY; ANTIGEN; BACTERIUM; BIOASSAY; DEVELOPING WORLD; DRUG DEVELOPMENT; EPIDEMIC; GENE EXPRESSION; HEPATITIS; IMMUNE RESPONSE; MEDICINE; RESEARCH WORK; RODENT; VACCINE; VIRUS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNOGENICITY; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; VACCINE PRODUCTION; VIRUS NEUTRALIZATION;

ANTIGENS, VIRAL; BASE SEQUENCE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; HEPATITIS A; LACTOCOCCUS LACTIS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; VIRAL VACCINES;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HEPATITIS A VIRUS; LACTOCOCCUS LACTIS; MUS;

EID: 84877778928     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-013-4722-3     Document Type: Article

References (40)

1. Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM, Aderem A (2005) Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci USA 102(26):9247-9252 (Pubitemid 40923549)
2. Bahey-El-Din M (2012) Lactococcus lactis-based vaccines from laboratory bench to human use: An overview. Vaccine 30(4):685-690
3. Bahey-El-Din M, Casey PG, Griffin BT, Gahan CG (2008) Lactococcus lactis-expressing listeriolysin O (LLO) provides protection and specific CD8(+) T cells against Listeria monocytogenes in the murine infection model. Vaccine 26(41):5304-5314
4. Berlec A, Jevnikar Z, Majhenic AC, Rogelj I, Strukelj B (2006) Expression of the sweet-tasting plant protein brazzein in Escherichia coli and Lactococcus lactis: a path toward sweet lactic acid bacteria. Appl Microbiol Biotechnol 73(1):158-165 (Pubitemid 44627737)
5. Berlec A, Ravnikar M, Strukelj B (2012) Lactic acid bacteria as oral delivery systems for biomolecules. Die Pharmazie - An International Journal of Pharmaceutical Sciences 67(11):891
6. Bermudez-Humaran LG, Langella P, Cortes-Perez NG, Gruss A, Tamez-Guerra RS, Oliveira SC, Saucedo-Cardenas O, Montes de Oca-Luna R, Le Loir Y (2003) Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect Immun 71(4):1887-1896 (Pubitemid 36368720)
7. Bermudez-Humaran LG, Cortes-Perez NG, Le Loir Y, Alcocer-Gonzalez JM, Tamez-Guerra RS, de Oca-Luna RM, Langella P (2004) An inducible surface presentation system improves cellular immunity against human papillomavirus type 16 E7 antigen in mice after nasal administration with recombinant lactococci. J Med Microbiol 53(Pt 5):427-433 (Pubitemid 38586510)
8. Cauchard S, Bermudez-Humaran LG, Blugeon S, Laugier C, Langella P, Cauchard J (2011) Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection. Vaccine 30(1):95-102
9. Cohen L, Benichou D, Martin A (2002) Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis. J Virol 76(15):7495-7505 (Pubitemid 34760972)
10. de Ruyter PG, Kuipers OP, de Vos WM (1996) Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl Environ Microbiol 62(10):3662-3667 (Pubitemid 26329592)
11. Douillard FP, O'Connell-Motherway M, Cambillau C, van Sinderen D (2011) Expanding the molecular toolbox for Lactococcus lactis: construction of an inducible thioredoxin gene fusion expression system. Microb Cell Fact 10:66
12. Drouault S, Corthier G, Ehrlich SD, Renault P (1999) Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 65(11):4881-4886
13. Emerson SU, Huang YK, Nguyen H, Brockington A, Govindarajan S, St Claire M, Shapiro M, Purcell RH (2002) Identification of VP1/2A and 2C as virulence genes of hepatitis A virus and demonstration of genetic instability of 2C. J Virol 76(17):8551-8559 (Pubitemid 34864050)
14. Feinstone SM, Kapikian AZ, Purcell RH (1973) Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 182(4116):1026-1028
15. Gauss-Muller V, Zhou MQ, von der Helm K, Deinhardt F (1990) Recombinant proteins VP1 and VP3 of hepatitis A virus prime for neutralizing response. J Med Virol 31(4):277-283 (Pubitemid 20305964)
16. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, Eng JK, Akira S, Underhill DM, Aderem A (2001) The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410(6832):1099-1103 (Pubitemid 32391041)
17. Hendrickx G, Van Herck K, Vorsters A, Wiersma S, Shapiro C, Andrus JK, Ropero AM, Shouval D, Ward W, Van Damme P (2008) Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J Viral Hepat 15(Suppl 2):1-15
18. Holo H, Nes IF (1989) High-Frequency Transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media. Appl Environ Microbiol 55(12):3119-3123 (Pubitemid 20002122)
19. Hughes JV, Stanton LW (1985) Isolation and immunizations with hepatitis A viral structural proteins: induction of antiprotein, antiviral, and neutralizing responses. J Virol 55(2):395-401 (Pubitemid 16239727)
20. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, Suntayakorn S, Suknuntapong T, Safary A, Tang DB, Boslego JW (1994) Protection against hepatitis A by an inactivated vaccine. Jama 271(17):1328-1334 (Pubitemid 24132458)
21. Khudyakov YE, Lopareva EN, Jue DL, Fang S, Spelbring J, Krawczynski K, Margolis HS, Fields HA (1999) Antigenic epitopes of the hepatitis A virus polyprotein. Virology 260(2):260-272 (Pubitemid 29382489)
22. Le Loir Y, Azevedo V, Oliveira SC, Freitas DA, Miyoshi A, Bermudez-Humaran LG, Nouaille S, Ribeiro LA, Leclercq S, Gabriel JE, Guimaraes VD, Oliveira MN, Charlier C, Gautier M, Langella P (2005) Protein secretion in Lactococcus lactis: an efficient way to increase the overall heterologous protein production. Microb Cell Fact 4(1):2 (Pubitemid 40230533)
23. Lei H, Sheng Z, Ding Q, Chen J, Wei X, Lam DM, Xu Y (2011) Evaluation of oral immunization with recombinant avian influenza virus HA1 displayed on the Lactococcus lactis surface and combined with the mucosal adjuvant cholera toxin subunit B. Clin Vaccine Immunol 18(7):1046-1051
24. Martin A, Lemon SM (2006) Hepatitis A virus: from discovery to vaccines. Hepatology 43(2 Suppl 1):S164-S172
25. Mierau I, Kleerebezem M (2005) Ten years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Appl Microbiol Biotechnol 68(6):705-717 (Pubitemid 41545614)
26. Mitchell LA, Joseph A, Kedar E, Barenholz Y, Galun E (2006) Mucosal immunization against hepatitis A: antibody responses are enhanced by co-administration of synthetic oligodeoxynucleotides and a novel cationic lipid. Vaccine 24(25):5300-5310 (Pubitemid 43833475)
27. Mizel SB, Bates JT (2010) Flagellin as an adjuvant: cellular mechanisms and potential. J Immunol 185(10):5677-5682
28. Moeini H, Rahim RA, Omar AR, Shafee N, Yusoff K (2011) Lactobacillus acidophilus as a live vehicle for oral immunization against chicken anemia virus. Appl Microbiol Biotechnol 90(1):77-88
29. Murthy KG, Deb A, Goonesekera S, Szabo C, Salzman AL (2004) Identification of conserved domains in Salmonella muenchen flagellin that are essential for its ability to activate TLR5 and to induce an inflammatory response in vitro. J Biol Chem 279(7):5667-5675 (Pubitemid 38220595)
30. Ott JJ, Irving G, Wiersma ST (2012) Long-term protective effects of hepatitis A vaccines. A systematic review. Vaccine. doi: 10.1016/j.vaccine.2012. 04.104
31. Raha AR, Varma NR, Yusoff K, Ross E, Foo HL (2005) Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl Microbiol Biotechnol 68(1):75-81 (Pubitemid 41202117)
32. Ravnikar M, Strukelj B, Obermajer N, Lunder M, Berlec A (2010) Engineered lactic acid bacterium Lactococcus lactis capable of binding antibodies and TNFalpha. Appl Environ Microbiol 76(20):6928-6932
33. Robertson BH, Brown VK, Holloway BP, Khanna B, Chan E (1989) Structure of the hepatitis A virion: identification of potential surface-exposed regions. Arch Virol 104(1-2):117-128 (Pubitemid 19069143)
34. Rustgi VK, Schleupner CJ, Krause DS (1995) Comparative study of the immunogenicity and safety of Engerix-B administered at 0, 1, 2 and 12 months and Recombivax HB administered at 0, 1, and 6 months in healthy adults. Vaccine 13(17):1665-1668 (Pubitemid 26013308)
35. Song L, Zhang Y, Yun NE, Poussard AL, Smith JN, Smith JK, Borisevich V, Linde JJ, Zacks MA, Li H, Kavita U, Reiserova L, Liu X, Dumuren K, Balasubramanian B, Weaver B, Parent J, Umlauf S, Liu G, Huleatt J, Tussey L, Paessler S (2009) Superior efficacy of a recombinant flagellin:H5N1 HA globular head vaccine is determined by the placement of the globular head within flagellin. Vaccine 27(42):5875-5884
36. Stapleton JT, Lange DK, LeDuc JW, Binn LN, Jansen RW, Lemon SM (1991) The role of secretory immunity in hepatitis A virus infection. J Infect Dis 163(1):7-11
37. Wells JM, Robinson K, Chamberlain LM, Schofield KM, Le Page RW (1996) Lactic acid bacteria as vaccine delivery vehicles. Antonie Van Leeuwenhoek 70(2-4):317-330 (Pubitemid 26355506)
38. WHO (2012) WHO position paper on hepatitis A vaccines - June 2012. Weekly epidemiological record 28-29(87):261-276
39. Yam KK, Pouliot P, N'Diaye MM, Fournier S, Olivier M, Cousineau B (2008) Innate inflammatory responses to the Gram-positive bacterium Lactococcus lactis. Vaccine 26(22):2689-2699
40. Zhang Q, Zhong J, Huan L (2010) Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination. Microbiol Res 166(2):111-120